Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-25 @ 2:45 AM
NCT ID:
NCT05547633
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Patient followed and treated for at least 2 years for bilateral neovascular form of age-related macular degeneration (AMD)
* At least one eye treated with ≥ 6 intravitreal injections during the year preceding preinclusion
* Express consent to participate in the study
* Affiliated with or beneficiary of a social security plan
Exclusion Criteria:
* Persons referred to in articles L1121-5 to L1121-8 of the CSP (corresponding to all protected persons: pregnant women, parturients, nursing mothers, persons deprived of liberty by judicial or administrative decision, minors, and persons under legal protection: guardianship or curatorship).
* Severe myopia (\> 6 diopters)
* Patient already being treated for acute or chronic sinusitis
* History of central serous chorioretinopathy or diffuse retinal epitheliopathy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05547633
Study Brief:
Protocol Section:
NCT05547633